250 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 5
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
SCN9ASodium voltage-gated channel alpha subunit 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Plasma membrane
Actin filaments
Focal adhesion sites
Tissue enhanced
SCNN1ASodium channel epithelial 1 alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Mixed
SCNN1BSodium channel epithelial 1 beta subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
SCNN1DSodium channel epithelial 1 delta subunitFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membrane
Actin filaments
Tissue enhanced
SCNN1GSodium channel epithelial 1 gamma subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Tissue enhanced
SCTRSecretin receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
SLC12A1Solute carrier family 12 member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Nucleus
Vesicles
Tissue enriched
SLC12A2Solute carrier family 12 member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Vesicles
Plasma membrane
Expressed in all
SLC12A3Solute carrier family 12 member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC12A4Solute carrier family 12 member 4FDA approved drug targets
Predicted membrane proteins
Transporters
EndosomesExpressed in all
SLC12A5Solute carrier family 12 member 5Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC18A1Solute carrier family 18 member A1FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC18A2Solute carrier family 18 member A2FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
SLC22A11Solute carrier family 22 member 11FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
SLC22A12Solute carrier family 22 member 12Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC22A6Solute carrier family 22 member 6FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC22A8Solute carrier family 22 member 8FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC25A4Solute carrier family 25 member 4Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
MitochondriaTissue enhanced
SLC25A5Solute carrier family 25 member 5FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
MitochondriaExpressed in all
SLC25A6Solute carrier family 25 member 6FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
MitochondriaExpressed in all
SLC52A2Solute carrier family 52 member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Expressed in all
SLC5A2Solute carrier family 5 member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC6A1Solute carrier family 6 member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
MitochondriaGroup enriched
SLC6A2Solute carrier family 6 member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mitochondria
Cytosol
Tissue enhanced
SLC6A3Solute carrier family 6 member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
VesiclesNot detected
SLC6A4Solute carrier family 6 member 4FDA approved drug targets
Predicted membrane proteins
Transporters
Golgi apparatus
Vesicles
Group enriched
SLC6A8Solute carrier family 6 member 8Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
SLC7A11Solute carrier family 7 member 11FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
VesiclesTissue enhanced
SLC8A1Solute carrier family 8 member A1FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Nucleoplasm
Plasma membrane
Tissue enhanced
SLCO2B1Solute carrier organic anion transporter family member 2B1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
SMOSmoothened, frizzled class receptorCancer-related genes
Disease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Mixed
SOAT1Sterol O-acyltransferase 1Enzymes
FDA approved drug targets
Predicted membrane proteins
Endoplasmic reticulumTissue enhanced
SQLESqualene epoxidaseEnzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Vesicles
Cytosol
Mixed
SRD5A1Steroid 5 alpha-reductase 1Cancer-related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Mixed
SRD5A2Steroid 5 alpha-reductase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Group enriched
SSTR1Somatostatin receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
SSTR2Somatostatin receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
CytosolTissue enhanced
SSTR5Somatostatin receptor 5FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Plasma membraneTissue enhanced
SV2ASynaptic vesicle glycoprotein 2AFDA approved drug targets
Predicted membrane proteins
CytosolTissue enhanced
TAAR1Trace amine associated receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
TACR1Tachykinin receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
TBXA2RThromboxane A2 receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Nuclear speckles
Plasma membrane
Mixed
TRHRThyrotropin releasing hormone receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Not detected
TRPA1Transient receptor potential cation channel subfamily A member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPM8Transient receptor potential cation channel subfamily M member 8FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
TRPV1Transient receptor potential cation channel subfamily V member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
TRPV3Transient receptor potential cation channel subfamily V member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Plasma membrane
Centrosome
Cytosol
Tissue enhanced
TSPOTranslocator proteinCancer-related genes
FDA approved drug targets
Predicted membrane proteins
Vesicles
Mitochondria
Cytosol
Expressed in all
UGCGUDP-glucose ceramide glucosyltransferaseEnzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all
VKORC1L1Vitamin K epoxide reductase complex subunit 1 like 1Enzymes
FDA approved drug targets
Predicted membrane proteins
Endoplasmic reticulumExpressed in all
« prev | Page of 5